Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Michael Mcgettrick (Glasgow, United Kingdom), Michael McGettrick, Selina Tsim, Kevin G. Blyth. Blood-staining of pleural fluid is an inaccurate predictor of pleural malignancy. Eur Respir J 2015; 46: Suppl. 59, 4347

Member's Comments

No comment yet.

Related content which might interest you: CT scanner for the pleural staging of pleural cancer: How accurate is this? Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 Solitary fibrous tumour of the pleural: Two malignant cases Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors Year: 2015 A computed tomography score to predict malignant pleural effusions Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies Year: 2013 An examination of the factors for successful pleurodesis against malignant pleural effusion (MPE) Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016 Predictive parameters of survival in malignant pleural effusion Source: International Congress 2015 – Malignant pleural effusions and mesothelioma Year: 2015 Ideal volume sampling in the diagnosis of malignant pleural effusions. Just how much is really enough? Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies Year: 2013 Lent score validation on patients with malignant pleural effusion Source: International Congress 2016 – Malignant pleural disease: diagnosis and management Year: 2016 Pericardiodesis in pericardial tamponade Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 A novel pleural-bladder pump for management of pleural effusion Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies Year: 2013 PET-CT predictors of mediastinal dissemination in lung cancer Source: International Congress 2014 – Outcome prediction and imaging in thoracic surgery Year: 2014 What outcome after pleurodesis in malignant pleural effusion in lung cancer? Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors Year: 2015 Role of Dr-70 immunoassay in suspected malignant pleural effusion Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 Malignant pleural effusion as the initial manifestation of gynecological malignancies Source: International Congress 2016 – Malignant pleural disease: diagnosis and management Year: 2016 Pleural ultrasonic elastography in the diagnosis of malignant pleural effusion Source: International Congress 2016 – Malignant pleural disease: diagnosis and management Year: 2016 Malignant pleural effusion (MPE) as debut of cancer Source: International Congress 2015 – Malignant pleural effusions and mesothelioma Year: 2015 Utility of sending pleural fluid for cytology at the time of thoracoscopy and pleural biopsy Source: International Congress 2016 – Malignant pleural disease: diagnosis and management Year: 2016 Diagnostic accuracy of pleural fluid cytology compared to pleural biopsy histology obtained via thoracoscopy Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 Detection of EpCAM-positive microparticles in pleural fluid: A new approach for the diagnosis of the tumoral origin of pleural effusions Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management Year: 2015 Talc pleurodesis for malignant pleural effusion - effect on survival: Case-control follow-up study Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma Year: 2014 Pleural mesothelioma with solitary simultaneous subcutaneous tissue metastasis of the abdominal wall at diagnosis - First clinical documentation Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases Year: 2013